Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$1.71B |
| 2 |
Eli Lilly
LLY
|
+$1.55B |
| 3 |
Tesla
TSLA
|
+$1.14B |
| 4 |
Boeing
BA
|
+$935M |
| 5 |
TE Connectivity
TEL
|
+$910M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.79B |
| 2 |
Visa
V
|
+$1.57B |
| 3 |
General Dynamics
GD
|
+$1.55B |
| 4 |
Morgan Stanley
MS
|
+$1.29B |
| 5 |
Exelon
EXC
|
+$1.15B |
Sector Composition
| 1 | Technology | 24.19% |
| 2 | Healthcare | 17.87% |
| 3 | Financials | 14.67% |
| 4 | Consumer Discretionary | 10.1% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1651
MasterBrand
MBC
$1.71B
| $805K | ﹤0.01% |
55,113
| – | – |
|
1652
Baxter International
BAX
$12.3B
| $804K | ﹤0.01% |
27,558
-709
| -3% | -$20.7K |
|
1653
Equity Lifestyle Properties
ELS
$11.9B
| $803K | ﹤0.01% |
12,054
+673
| +6% | +$44.8K |
|
1654
Arq
ARQ
$306M
| $793K | ﹤0.01% |
+104,745
| New | +$793K |
|
1655
Amylyx Pharmaceuticals
AMLX
$1.24B
| $793K | ﹤0.01% |
+209,708
| New | +$793K |
|
1656
iShares Russell 1000 Value ETF
IWD
$63.8B
| $788K | ﹤0.01% |
4,254
+44
| +1% | +$8.15K |
|
1657
Lumentum
LITE
$11.4B
| $784K | ﹤0.01% |
+9,337
| New | +$784K |
|
1658
Recursion Pharmaceuticals
RXRX
$2.11B
| $777K | ﹤0.01% |
114,945
+9,927
| +9% | +$67.1K |
|
1659
Stanley Black & Decker
SWK
$12B
| $777K | ﹤0.01% |
9,673
+1,188
| +14% | +$95.4K |
|
1660
Aspen Aerogels
ASPN
$543M
| $769K | ﹤0.01% |
64,700
-85,932
| -57% | -$1.02M |
|
1661
Dynavax Technologies
DVAX
$1.1B
| $763K | ﹤0.01% |
59,777
-8,247
| -12% | -$105K |
|
1662
Vera Therapeutics
VERA
$1.52B
| $762K | ﹤0.01% |
18,018
-2,053
| -10% | -$86.8K |
|
1663
Southern California Bancorp
BCAL
$559M
| $760K | ﹤0.01% |
45,963
| – | – |
|
|
TSVT
1664
DELISTED
2seventy bio
TSVT
| $754K | ﹤0.01% |
256,569
-5,471
| -2% | -$16.1K |
|
1665
Heron Therapeutics
HRTX
$193M
| $747K | ﹤0.01% |
488,122
-8,105
| -2% | -$12.4K |
|
1666
Revvity
RVTY
$9.62B
| $743K | ﹤0.01% |
6,655
+776
| +13% | +$86.6K |
|
1667
Atea Pharmaceuticals
AVIR
$249M
| $732K | ﹤0.01% |
218,509
-3,053
| -1% | -$10.2K |
|
1668
SIGA Technologies
SIGA
$639M
| $723K | ﹤0.01% |
120,225
+8,028
| +7% | +$48.2K |
|
1669
Mine Safety
MSA
$6.63B
| $721K | ﹤0.01% |
4,351
-274
| -6% | -$45.4K |
|
1670
Summit Therapeutics
SMMT
$14.1B
| $716K | ﹤0.01% |
40,119
-4,069
| -9% | -$72.6K |
|
1671
American Financial Group
AFG
$11.7B
| $692K | ﹤0.01% |
5,052
+164
| +3% | +$22.5K |
|
1672
Arcutis Biotherapeutics
ARQT
$2.07B
| $686K | ﹤0.01% |
49,267
-3,882
| -7% | -$54.1K |
|
1673
Toast
TOST
$23.3B
| $674K | ﹤0.01% |
18,498
-13,822
| -43% | -$504K |
|
1674
BioCryst Pharmaceuticals
BCRX
$1.66B
| $670K | ﹤0.01% |
89,057
-18,763
| -17% | -$141K |
|
1675
D.R. Horton
DHI
$53B
| $669K | ﹤0.01% |
4,787
-38,949
| -89% | -$5.45M |
|